Comparative Outcomes of Loop Ileostomy and Loop Transverse Colostomy Following Curative Resection for Rectal Cancer
Annals of African Medicine · 22.07.2026
DOI: 10.4103/aam.aam_423_26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of African Medicine, online erschienen am 22.07.2026. Verfasst von Karim Shenit und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Colorectal Surgery, Royal Lancaster Infirmary, University Hospitals of Morecambe Bay NHS Foundation Trust, Lancaster, United Kingdom. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Introduction
Temporary diversion of the fecal stream with a loop stoma is commonly performed to safeguard against an anastomotic failure and cause further complications. Commonly used stomas include loop ileostomy (LI) and loop transverse colostomy (LTC). Both of these techniques have their own complication profiles. This study highlights the comparison of patient outcomes and quality of life in these two stoma groups following curative resection for rectal cancer.
Methods
This randomized comparative study was carried out in the Colorectal Surgery Unit of Alexandria University Hospitals, Alexandria, Egypt, from February 2020 to February 2021 in patients undergoing curative resection for rectal cancer. Forty adult patients were enrolled and randomized (1:1) to undergo either LI or LTC. The 36-item short-form survey questionnaire was used to assess the quality of life. The statistical analysis of the collected data was done using IBM SPSS Statistics, Windows version 27.0, IBM Corp., Armonk, New York, USA.
Results
LI was found to be significantly associated with shorter stoma creation, earlier output, and reduced hospital stay. However, LI had significantly higher 30-day complication rates, attributed mostly to dehydration and skin irritation. At 1 month, colostomy patients reported better quality of life and fewer pouch changes. Stoma reversal was quicker with ileostomy with comparable postoperative morbidity.
Conclusion
LI despite offering a faster construction and earlier recovery, carries the risk of early metabolic and skin complications. LTC, on the contrary, offers a better quality of life and fewer early complications, at the cost of a longer surgery. Thoughtful, patient-centered selection remains the cornerstone of optimal surgical practice.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Colorectal Surgery, Royal Lancaster Infirmary, University Hospitals of Morecambe Bay NHS Foundation Trust, Lancaster, United Kingdom.
- Department of General Surgery, Manchester University NHS Foundation Trust, Northwest Deanery, England, United Kingdom.
- Department of General Surgery, Kasturba Medical College Mangalore, Manipal Academy of Higher Education, Manipal, India.
- Department of Colorectal Surgery, York and Scarborough Teaching Hospitals NHS Foundation Trust, Yorkshire, United Kingdom.
- Department of Experimental and Clinical Surgery, Medical Research Institute, Alexandria University, Alexandria, Egypt.
- Department of Colorectal Surgery, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Zitieren
APA
Shenit, K., Ahmed, T., Colaco, S. M., Attia, K., Hamza, A., Zakaria, M., & Ashoush, F. (2026). Comparative Outcomes of Loop Ileostomy and Loop Transverse Colostomy Following Curative Resection for Rectal Cancer. Annals of African Medicine. https://doi.org/10.4103/aam.aam_423_26
Vancouver
Shenit K, Ahmed T, Colaco SM, Attia K, Hamza A, Zakaria M, et al. Comparative Outcomes of Loop Ileostomy and Loop Transverse Colostomy Following Curative Resection for Rectal Cancer. Annals of African Medicine. 2026. doi:10.4103/aam.aam_423_26
BibTeX
@article{Shenit2026,
author = {Shenit, Karim and Ahmed, Talha and Colaco, Sumith Marian and Attia, Kareem and Hamza, Alaa and Zakaria, Mohamed and Ashoush, Fouad},
title = {Comparative Outcomes of Loop Ileostomy and Loop Transverse Colostomy Following Curative Resection for Rectal Cancer},
journal = {Annals of African Medicine},
year = {2026},
doi = {10.4103/aam.aam_423_26}
}
EUVIMED